drugset / Trial / NCT04144712

Caffeine as Respiratory Stimulant in Preterm Infants

NCT04144712

Phase 1 Unknown 80 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

comparison between rate of occurance of apnea of prematurity AOP when using high and low dose caffeine

Timeline

Start
2019-04-01
Primary completion
2020-10
Completion
2020-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule

Indications